Filing Details

Accession Number:
0001181431-11-047817
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-02 10:49:42
Reporting Period:
2011-08-31
Filing Date:
2011-09-02
Accepted Time:
2011-09-02 10:49:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1321178 Moshe Arkin C/o Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-31 13,549 $94.55 5,049,573 No 4 S Indirect By Nichsei Arkin Ltd
Common Stock Disposition 2011-08-31 13,715 $95.18 5,035,828 No 4 S Indirect By Nichsei Arkin Ltd
Common Stock Disposition 2011-08-31 52,591 $96.20 4,983,267 No 4 S Indirect By Nichsei Arkin Ltd
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Nichsei Arkin Ltd
No 4 S Indirect By Nichsei Arkin Ltd
No 4 S Indirect By Nichsei Arkin Ltd
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,130 Direct
Footnotes
  1. The price in column 4 is a weighted average. The prices actually received ranged from $93.83 to $94.83. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
  2. The price in column 4 is a weighted average. The prices actually received ranged from $94.84 to $95.84. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
  3. The price in column 4 is a weighted average. The prices actually received ranged from $95.85 to $96.79. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range